
11 - 50 employees
Founded 2008
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $200M Post-IPO Equity - Immuneering on 2025-09
Biotechnology • Pharmaceuticals
Immuneering Corporation is a clinical-stage biotechnology company developing a novel class of oncology therapies called Deep Cyclic Inhibitors, which use rhythmic dosing to outpace cancer adaptation, improve tolerability, and extend patient survival and quality of life. The company advances a pipeline through clinical trials, collaborates with partners, and emphasizes scientific research and publications to transform cancer treatment while reducing side effects of traditional continuous-inhibition therapies.
🕒 December 18, 2025
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2008
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $200M Post-IPO Equity - Immuneering on 2025-09
Biotechnology • Pharmaceuticals
Immuneering Corporation is a clinical-stage biotechnology company developing a novel class of oncology therapies called Deep Cyclic Inhibitors, which use rhythmic dosing to outpace cancer adaptation, improve tolerability, and extend patient survival and quality of life. The company advances a pipeline through clinical trials, collaborates with partners, and emphasizes scientific research and publications to transform cancer treatment while reducing side effects of traditional continuous-inhibition therapies.
• Lead Clinical Pharmacology strategy across early and late stage development, integrating PK, PD, exposure–response, and biomarker data to inform dose selection, regimen, and overall study design. • Own model informed drug development (MIDD) plans (e.g., population PK, PBPK, and quantitative systems approaches) to optimize trial designs and decision points from first in human through pivotal phases. • Author and review CP deliverables for protocols, clinical development plans, IBs, SAPs, and regulatory documents (IND/IMPD/NDA/BLA/MAA), ensuring clarity, traceability, and compliance. • Drive analysis & reporting of PK/PD and exposure–response results (internal and CRO executed), ensuring scientific integrity, reproducibility, and timely insights for program teams and governance. • Establish bioanalytical strategy and standards (method selection/validation, sample handling, and data QC) in partnership with Translational Medicine and external labs/CROs. • Lead Health Authority interactions for CP topics; prepare briefing materials, address IRs, and represent the function in meetings with FDA, EMA, and other agencies. • Provide cross functional leadership with Clinical, Biostatistics, Data Science, CMC, and Regulatory to integrate quantitative evidence into go/no go decisions and portfolio prioritization. • Vendor selection and management for CP related CROs; define scopes, oversee execution, and ensure deliverables meet quality and timeline commitments. • Advance standards & governance (CDISC/ADaM for PK datasets, data pipelines, analysis reproducibility), championing best practices and inspection readiness for a GxP environment. • People collaborations: Must roll up sleeves and be a doer who wants to be into the details themselves. Mentor staff cross functionally and foster an inclusive, high-performance culture consistent with Immuneering values.
• PhD or PharmD (or MS with significant industry experience) in Clinical Pharmacology, Pharmacokinetics, Pharmaceutical Sciences, or related quantitative field required. • Minimum of 5+ years in biotech/pharma Clinical Pharmacology required, more years of experience is a plus, including end-to-end ownership of CP strategy, MIDD, and regulatory submissions across Phase 1–3. • Population PK/PD modeling (NONMEM, Monolix), PBPK (Simcyp, GastroPlus), and exposure–response methods. • Bioanalytical method development/validation oversight and data integrity in GxP contexts. • Authoring high quality CP sections for protocols, IBs, and regulatory dossiers; direct participation in FDA/EMA meetings.
• Health insurance • Retirement plans • Paid time off • Professional development
Apply Now🕒 December 13, 2025
10,000+ employees
🏠 Real Estate
Director of National Capital Markets Research at Colliers leading research insights for capital markets strategy. Driving client engagement and revenue growth through accurate market intelligence and collaboration.
🕒 December 8, 2025
201 - 500
📚 Education
🤝 Non-profit
🌍 Social Impact
Director of Major Gifts cultivating and managing relationships with major donors. Driving $21M in philanthropic annual revenue for DREAM's programs.
🕒 December 1, 2025
1001 - 5000
🏦 Banking
💳 Fintech
💸 Finance
Product Director shaping U.S. market strategies for Engine's SaaS banking platform. Leading client relationships and product roadmap alignment to transform banking.
🕒 November 27, 2025
5001 - 10000
🤝 B2B
🏢 Enterprise
💸 Finance
Consulting Director at Innosight leading healthcare provider strategy and innovation initiatives. Engaging with C-suite executives to deliver impactful solutions in a dynamic environment.
🕒 November 25, 2025
11 - 50
🤖 Artificial Intelligence
☁️ SaaS
🤝 B2B
Director of Strategic Accounts at Qumis driving expansion revenue and partnerships in the P&C insurance sector. Collaborating with the founding team for growth strategy and product development.